Literature DB >> 18685857

[Diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases].

C Dejaco1, T Seifert, C Duftner, M K Storch, F Fazekas, M Schirmer.   

Abstract

Patients with inflammatory rheumatic diseases frequently report symptoms that may indicate an involvement of central and peripheral nervous system in addition to the known musculoskeletal symptoms. The possible symptoms can be as varied as the disease mechanism which causes them. Early correct diagnosis, adequate therapy and regular monitoring of these patients are necessary to prevent permanent disability. This article summarizes current literature on the diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases including systemic Lupus erythematodes, Behçet's disease, Sjögren's syndrome, systemic vasculitides and sarcoidosis.

Entities:  

Mesh:

Year:  2008        PMID: 18685857     DOI: 10.1007/s00393-008-0339-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  [Cerebral vasculitis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 3.  Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.

Authors:  Nicolò Pipitone; Ignazio Olivieri; Angela Padula; Salvatore D'angelo; Angelo Nigro; Giulio Zuccoli; Luigi Boiardi; Carlo Salvarani
Journal:  Arthritis Rheum       Date:  2008-02-15

4.  Central nervous system compromise in primary Sjögren's syndrome.

Authors:  Juan-Manuel Anaya; Luis A Villa; Lucas Restrepo; Jose F Molina; Rubén D Mantilla; Sergio Vargas
Journal:  J Clin Rheumatol       Date:  2002-08       Impact factor: 3.517

5.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

Review 6.  Vasculitis of the nervous system.

Authors:  A Siva
Journal:  J Neurol       Date:  2001-06       Impact factor: 4.849

7.  Etanercept plus standard therapy for Wegener's granulomatosis.

Authors: 
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

8.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

9.  Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Authors:  Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

10.  Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

Authors:  Naomi Tsurikisawa; Masami Taniguchi; Hiroshi Saito; Hideo Himeno; Akihiko Ishibashi; Shunsuke Suzuki; Kazuo Akiyama
Journal:  Ann Allergy Asthma Immunol       Date:  2004-01       Impact factor: 6.347

View more
  1 in total

1.  [Expectations of rheumatologists on imaging results].

Authors:  C Dejaco; C Duftner; M Schirmer
Journal:  Radiologe       Date:  2012-02       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.